Tirzepatide

Tirzepatide is a new medication for adults with type 2 diabetes. It is an injectable medicine that is taken once a week to help control blood sugar levels. It works by increasing the amount of insulin released from the pancreas and helping the body use insulin more effectively. It also helps reduce the amount of glucose produced by the liver. Tirzepatide can help reduce the risk of serious complications associated with diabetes, such as heart disease, stroke, and kidney disease'

Tirzepatide is a medication used for two main purposes:

1. Treatment of type 2 diabetes: It helps improve blood sugar control in adults with this condition.
2. Chronic weight management: It aids in weight loss when used alongside a reduced-calorie diet and increased physical activity.

Here's a closer look at Tirzepatide:

• Type: Dual GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1) receptor agonist [1, 2].
• Brand Names: Mounjaro, Zepbound [4].
• Administration: Subcutaneous injection (under the skin) [4].

How it Works:

• Tirzepatide mimics the effects of two natural gut hormones: GIP and GLP-1 [2].
  • GIP: Stimulates insulin release from the pancreas, lowering blood sugar levels [2].
  • GLP-1: Suppresses glucagon (a hormone that raises blood sugar) secretion, slows down stomach emptying, and increases feelings of satiety (fullness) to promote weight loss [2].

Benefits:

• Improved glycemic control in type 2 diabetes [2].
• Significant weight reduction, with studies showing promising results for long-term weight management [3].

Important Considerations:

• Tirzepatide is not a substitute for a healthy diet and exercise for diabetes management or weight loss [2].
• It's not approved for treating type 1 diabetes or hasn't been studied in patients with pancreatitis [2].
• It can cause side effects like nausea, vomiting, diarrhea, constipation, stomach pain, and low blood sugar (hypoglycemia) [2]